Form 4: Verastem Director Sells Shares Under 10b5-1 Plan

Verastem Director Paul A. Bunn sold 8,333 shares of common stock for a weighted average price of $9.06 per share pursuant to a Rule 10b5-1 trading plan.

Summary

• Paul A. Bunn, a Director of Verastem, Inc. (VSTM), reported the sale of common stock.
• The transaction involved 8,333 shares of common stock.
• The shares were sold at a weighted average price of $9.06 per share.
• Individual sales prices ranged from $8.70 to $9.33.
• The sale was executed on October 9, 2025.
• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan.
• Following the reported transaction, Paul A. Bunn directly beneficially owns 8,333 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a pre-planned sale under Rule 10b5-1, which is a routine event and generally considered neutral. It does not indicate a change in company fundamentals or management's immediate outlook.

Future Outlook

N/A

Industry Context

This filing reports a routine insider transaction by a director of Verastem, Inc., a biotechnology company. Such transactions are common and typically do not reflect broader industry trends unless they are unusually large or indicative of a significant shift in insider sentiment across the sector.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even if pre-planned, can sometimes be perceived negatively, though the relatively small volume and 10b5-1 plan mitigate significant concern. It does not directly impact company operations or financial performance.

Key Dates

Keywords

Verastem, VSTM, Insider Trading, Form 4, Stock Sale, Director, Paul Bunn, 10b5-1 Plan, Equity Transaction